Hers GLP-1 Weight Loss Review 2026: FDA-Approved Wegovy, Not Compounded
By Charly P. · Published July 31, 2026 · 10 min read
Almost every GLP-1 telehealth platform we review dispenses compounded semaglutide. Hers does not, and that single fact is what this review is really about. Hers prescribes FDA-approved Wegovy, the branded semaglutide made by Novo Nordisk, offered as a daily pill from $149/month or a once-weekly injectable pen from $199/month. That puts it at roughly double the monthly cost of the cheapest compounded programs on our list. The question worth answering is not whether Hers is expensive, it plainly is relative to its peers, but whether the specific thing you are paying extra for is a thing you actually need.
Hers GLP-1 at a Glance
| Provider | Hers (Hims & Hers Health) |
|---|---|
| Program Type | Telehealth weight loss with brand-name GLP-1 |
| Medication | Wegovy (semaglutide), FDA-approved, not compounded |
| Wegovy Pill | From $149/month |
| Wegovy Injectable Pen | From $199/month |
| Prescription Required | Yes, by a licensed clinician after online intake |
| Insurance | Not required; Hers does not bill insurance |
| Ongoing Care | Personalized care team with dose check-ins |
| In-Person Visits | None, fully online |
| Tirzepatide Available | No, semaglutide only |
| Commitment | No insurance requirement; cancel anytime |
About Hers: What Makes It Different
Hers is the women's telehealth brand of Hims & Hers Health, a publicly traded company that has been operating direct-to-consumer prescription care since 2017. Its weight loss program is built around brand-name Wegovy rather than a compounded equivalent, supported by a care team that handles dose escalation and check-ins over the course of treatment.
To be precise about what “FDA-approved” means here: Wegovy is a finished drug product that has been through the FDA's review process for safety, efficacy, and manufacturing quality, and is produced in FDA-registered facilities under that approval. Compounded semaglutide is prepared to order by a licensed compounding pharmacy under state pharmacy board oversight. It uses the same active molecule, but the finished preparation itself is not individually evaluated by the FDA. Both routes are legal; they carry different regulatory guarantees.
Hers Pricing 2026
Hers prices the two Wegovy formats separately. Both are self-pay rates that include the clinical review and ongoing care team support.
| Wegovy Pill (daily oral) | $149/month |
|---|---|
| Wegovy Injectable Pen (weekly) | $199/month |
| Medication Type | FDA-approved brand-name semaglutide |
| Insurance Billing | None, self-pay |
| Included | Clinical review, personalized care team, dose check-ins |
| Contract | No long-term commitment; cancel anytime |
How That Compares
| Provider | Semaglutide From | Medication Type |
|---|---|---|
| Hers | $149/mo (pill) | FDA-approved Wegovy |
| Embody | $69/mo | Compounded |
| altRx | $89/mo | Compounded |
| TrimRx | $149/mo | Compounded |
| Yucca Health | $146/mo | Compounded |
The comparison that actually matters is the bottom half of that table, not the top. Against TrimRx at $149/month and Yucca Health at $146/month, Hers is priced at parity while supplying a brand-name product rather than a compounded one. If you were already shopping in the $145–150 band, Hers is arguably the better value in it. It is only against the $69–89 tier that the premium becomes a real trade-off.
How Hers Works
- 1.Complete the Online Intake
Answer questions covering your weight history, medical background, and current medications. No in-person appointment and no insurance details required.
- 2.Clinician Review
A licensed clinician reviews your submission, determines eligibility, and recommends a format, the daily oral pill or the once-weekly injectable pen.
- 3.Medication Ships to You
If approved, brand-name Wegovy is shipped to your home. Because it is an FDA-approved finished product, it arrives in manufacturer packaging rather than a compounded preparation.
- 4.Ongoing Dose Check-Ins
Your care team monitors tolerability through the titration schedule and adjusts dosing over time, which is where most GLP-1 side effects are managed.
Pros and Cons
Pros
- ✓FDA-approved brand-name Wegovy, not a compounded preparation
- ✓Both formats available: daily oral pill and weekly injectable pen
- ✓Oral option removes the injection entirely for needle-averse patients
- ✓Personalized care team with ongoing dose check-ins included
- ✓No insurance required and no long-term contract
- ✓Backed by a publicly traded telehealth operator with a long trading history
- ✓Priced at parity with several compounded programs in the $146–149 band
Cons
- ✗Roughly double the cost of the cheapest compounded programs
- ✗No compounded or generic alternative offered as a lower-cost tier
- ✗No tirzepatide option, semaglutide only
- ✗Does not bill insurance, so the full cost is out of pocket
- ✗Brand-name supply is subject to manufacturer availability in a way compounded supply is not
Who Hers Is For
Hers makes sense for a specific patient: someone who has decided that an FDA-approved finished product is non-negotiable, and who is willing to pay for that certainty. That includes patients who are uneasy about compounding oversight, patients whose clinicians have advised brand-name only, and patients who want the option of a daily pill instead of a weekly injection.
It is the wrong choice if cost is your binding constraint. At $149/month you are paying more than twice what Embody charges for compounded semaglutide, and the active molecule is the same in both. It is also the wrong choice if you want tirzepatide, which several competitors offer alongside semaglutide but Hers does not.
Safety and Regulatory Context
According to the FDA, semaglutide is approved for chronic weight management under specific clinical criteria, and the agency has published guidance distinguishing compounded semaglutide from the approved finished products. Hers dispenses the approved product, which is the basis of its positioning.
The CDC reports that roughly 40% of U.S. adults have obesity, which is the demand backdrop against which both brand-name and compounded GLP-1 telehealth has expanded so quickly.
Bottom Line
Our Editorial Take
Hers is the clearest expression of a trade-off the rest of this category tries to blur: you can have the FDA-approved product or you can have the low price, and Hers has picked the first without apology. What changed my read on it is the mid-tier comparison. Framed against $69 compounded semaglutide, $149 looks like a steep premium. Framed against TrimRx and Yucca Health, which charge about the same for a compounded preparation, Hers looks like the better-specified option at the same price.
The oral format is the other underrated part of the offer. A daily Wegovy pill at $149/month is a genuinely different product from a weekly injection, and for anyone whose real barrier to GLP-1 therapy has been the needle rather than the cost, it is the reason to look here first. The gap in the lineup is tirzepatide, which is absent entirely, so anyone wanting the dual GIP/GLP-1 molecule needs to shop elsewhere, such as altRx.
Caveat: brand-name GLP-1 supply depends on manufacturer availability. Confirm current stock and pricing directly with Hers before committing.
Hers Alternatives
Looking for alternatives to Hers? Here are the top-rated GLP-1 weight loss programs we recommend:
Recommended Providers
Our editorial team’s top picks for this category.
Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.